Editorial: stepwise risk stratification for both F3 and F4 fibrosis stage in NAFLD patients

Aliment Pharmacol Ther. 2018 Dec;48(11-12):1317-1318. doi: 10.1111/apt.15024.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Fibrosis
  • Germany
  • Humans
  • Liver Cirrhosis*
  • Non-alcoholic Fatty Liver Disease*
  • Risk Assessment